Activity in the Addiction Treatment Market in 2026 and Beyond
Activity in the addiction treatment and substance use disorder markets has been cautious throughout 2026, as players prepare for headwinds from Medicaid changes effective January. While deals are still occurring, increased investor scrutiny focuses on consolidation, diligence, capital allocation, and selective buyers.
In 2027, operators can expect heightened emphasis on:
- Payer diversification
- Step-down admissions
- Patient and workforce retention
These factors will drive initial transactions, with investors considering in-network revenues, payer concentration, care continuums, retention, and quality measurements.
"The market has evolved from a volume story to a quality story," noted Moses Adubi, principal of healthcare services investment at Deerfield Management.
Providers and operators should focus on:
- Strengthening reporting infrastructures
- Data analysis demonstrating market readiness
- Compliance practices
- Financial trends showcasing sustainable operations
- Clinical or operational differentiation
"The most attractive acquisition opportunities... demonstrate some level of... differentiation," said Marshal Salomon, CEO of BayMark Health Services.
As the year progresses, those seeking to invest in 2027 will prioritize companies with quality outcomes and synergistic merges, considering the EBITDA and return on multiples long-term viability.
"Being with a group that understands quality is the most important part," emphasized Justin Adams, COO of Bradford Health Services.